Viewing data from:

LORYNA

ANDA

DROSPIRENONE; ETHINYL ESTRADIOL | A079221 | XIROMED PHARMA ESPANA SL

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: YAZ(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Loryna (2023)

Total Spending

$209K

Total Claims

3,912

Beneficiaries

1,088

Avg Cost/Unit

$0.92

Spending Trend

$80K(2019)→$125K(2020)→$188K(2021)→$189K(2022)→$209K(2023)

YoY Change:-5.7%

5yr CAGR:-6.7%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 3MG;0.02MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Mar 28, 2011

No patent or exclusivity listings for this strength.